BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 18222217)

  • 21. Biologic effects of radiofrequency thermal ablation on non-small cell lung cancer: results of a pilot study.
    Ambrogi MC; Fontanini G; Cioni R; Faviana P; Fanucchi O; Mussi A
    J Thorac Cardiovasc Surg; 2006 May; 131(5):1002-6. PubMed ID: 16678582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is radiofrequency thermal ablation a safe and effective procedure in the treatment of pulmonary malignancies?
    Huang L; Han Y; Zhao J; Wang X; Cheng Q; Li X; Xu H; Gao K
    Eur J Cardiothorac Surg; 2011 Mar; 39(3):348-51. PubMed ID: 20663679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation.
    Beland MD; Wasser EJ; Mayo-Smith WW; Dupuy DE
    Radiology; 2010 Jan; 254(1):301-7. PubMed ID: 20032160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiofrequency ablation: a safe and effective treatment in nonoperative patients with early-stage lung cancer.
    Healey TT; Dupuy DE
    Cancer J; 2011; 17(1):33-7. PubMed ID: 21263265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minimally invasive techniques for managing pulmonary metastases: video-assisted thoracic surgery and radiofrequency ablation.
    Ketchedjian A; Daly B; Luketich J; Fernando HC
    Thorac Surg Clin; 2006 May; 16(2):157-65. PubMed ID: 16805205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer: results in 20 nonsurgical candidates.
    Hiraki T; Gobara H; Iishi T; Sano Y; Iguchi T; Fujiwara H; Tajiri N; Sakurai J; Date H; Mimura H; Kanazawa S
    J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1306-12. PubMed ID: 17976467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Survival after surgical resection for stage IV non-small cell lung cancer].
    Kawai H; Matsuzaki I; Ogawa J
    Kyobu Geka; 2006 Jan; 59(1):21-3. PubMed ID: 16440680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiofrequency and microwave ablation of lung tumors.
    Abbas G; Pennathur A; Landreneau RJ; Luketich JD
    J Surg Oncol; 2009 Dec; 100(8):645-50. PubMed ID: 20017162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival and risk factors of surgically treated mediastinal invasion T4 non-small cell lung cancer.
    Yang HX; Hou X; Lin P; Rong TH; Yang H; Fu JH
    Ann Thorac Surg; 2009 Aug; 88(2):372-8. PubMed ID: 19632375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Surgical indication for non-small cell lung cancer with synchronous distant metastases].
    Hirose M; Ota S; Ishibashi H
    Kyobu Geka; 2006 Jan; 59(1):15-20. PubMed ID: 16440679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival of patients with true pathologic stage I non-small cell lung cancer.
    Cerfolio RJ; Bryant AS
    Ann Thorac Surg; 2009 Sep; 88(3):917-22; discussion 922-3. PubMed ID: 19699920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ablative treatments for lung tumors: radiofrequency ablation, stereotactic radiosurgery, and microwave ablation.
    Abbas G; Schuchert MJ; Pennathur A; Gilbert S; Luketich JD
    Thorac Surg Clin; 2007 May; 17(2):261-71. PubMed ID: 17626404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percutaneous radiofrequency ablation for unresectable pulmonary metastases from renal cell carcinoma.
    Soga N; Yamakado K; Gohara H; Takaki H; Hiraki T; Yamada T; Arima K; Takeda K; Kanazawa S; Sugimura Y
    BJU Int; 2009 Sep; 104(6):790-4. PubMed ID: 19338555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients.
    Simon CJ; Dupuy DE; DiPetrillo TA; Safran HP; Grieco CA; Ng T; Mayo-Smith WW
    Radiology; 2007 Apr; 243(1):268-75. PubMed ID: 17392258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk.
    Yildizeli B; Dartevelle PG; Fadel E; Mussot S; Chapelier A
    Ann Thorac Surg; 2008 Oct; 86(4):1065-75; discussion 1074-5. PubMed ID: 18805134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass.
    Levinson AW; Su LM; Agarwal D; Sroka M; Jarrett TW; Kavoussi LR; Solomon SB
    J Urol; 2008 Aug; 180(2):499-504; discussion 504. PubMed ID: 18550123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiofrequency ablation: emerging therapy for the small pulmonary nodule?
    Kucharczuk JC
    Semin Thorac Cardiovasc Surg; 2005; 17(2):134-7. PubMed ID: 16087081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung radiofrequency ablation for the treatment of unresectable recurrent non-small-cell lung cancer after surgical intervention.
    Kodama H; Yamakado K; Takaki H; Kashima M; Uraki J; Nakatsuka A; Takao M; Taguchi O; Yamada T; Takeda K
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):563-9. PubMed ID: 21748451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study).
    Lencioni R; Crocetti L; Cioni R; Suh R; Glenn D; Regge D; Helmberger T; Gillams AR; Frilling A; Ambrogi M; Bartolozzi C; Mussi A
    Lancet Oncol; 2008 Jul; 9(7):621-8. PubMed ID: 18565793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiofrequency thermal ablation in the treatment of lung malignancies.
    Gadaleta C; Catino A; Mattioli V
    In Vivo; 2006; 20(6A):765-7. PubMed ID: 17203764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.